Elevation Oncology Inc (ELEV) — Financial Flexibility Index
Elevation Oncology Inc (ELEV) has a Financial Flexibility Index of -0.36x as of March 2025. Free cash flow of $-12.71 Million (operating CF $-12.71 Million minus capex $0.00) represents 0% of total liabilities ($35.49 Million). Check strategic asset allocation of Elevation Oncology Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elevation Oncology Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Elevation Oncology Inc across 6 annual periods. See Elevation Oncology Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Elevation Oncology Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Elevation Oncology Inc. For the full company profile including market capitalisation, see ELEV market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.02x | $-36.36 Million | $-36.36 Million | $35.60 Million | ▲ +37.7% |
| 2023 | -1.64x | $-56.18 Million | $-56.18 Million | $34.28 Million | ▲ +13.4% |
| 2022 | -1.89x | $-85.40 Million | $-85.48 Million | $45.13 Million | ▲ +44.7% |
| 2021 | -3.42x | $-30.08 Million | $-30.17 Million | $8.80 Million | ▼ -2808.2% |
| 2020 | -0.12x | $-12.23 Million | $-12.30 Million | $103.99 Million | ▲ +83.0% |
| 2019 | -0.69x | $-5.38 Million | $-5.45 Million | $7.79 Million | — |